A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents

• R. Ke,
• J.M. Conway,
• A.S. Perelson

Affiliations

R. Ke

Department of Mathematics, North Carolina State University, USA

J.M. Conway

Department of Mathematics, Pennsylvania State University, USA

A.S. Perelson

Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, USA